Market Tracker

07/28 6:13am ET

ImmuCell Corp (NASDAQ:ICCC)

7.04
Delayed Data
As of Jul 27
 +0.26 / +3.83%
Today’s Change
5.60
Today|||52-Week Range
11.40
-6.63%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.78
Today’s open6.90
Day’s range6.90 - 7.06
Volume701
Average volume (3 months)5,157
Market cap$28.3M
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio20.0
Price/Sales2.32
Price/Book1.95

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc-0.02-8.92%
ORPNBio Blast Pharma Ltd-0.03-1.69%
VTGNVistaGen Therapeutic...-0.24-6.48%
BPMXBiopharmx Corp-0.06-6.38%
Data as of 07/27/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts